Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 251 is a pseudogene, meaning it is a DNA sequence related to the functional non-coding RNA gene RN7SK but has lost the ability to encode a functional RNA molecule or protein and does not have a known biological function or therapeutic relevance[3]. There is no evidence to suggest that this pseudogene is involved in disease, drug targeting, or any physiological biological process. Important Context: - *RN7SKP251* should not be confused with the functional **RN7SK small nuclear RNA** (*RN7SK*), which is a non-coding RNA scaffold in the 7SK small nuclear ribonucleoprotein (snRNP) complex and plays a crucial regulatory role in **transcriptional elongation** by controlling activity of the positive transcription elongation factor P-TEFb[1][2][5]. - Only *RN7SK* is involved in transcription regulation, cell differentiation, and has implications in disease states such as cancers, HIV replication, and neuronal development[4][5]. In summary: **RN7SKP251 (RN7SK pseudogene 251)** is not a therapeutic target, has no documented biological or disease roles, drug interactions, or biomarker value; its listing is likely incorrect for drug discovery or therapeutic targeting purposes[3]. If the intent was to refer to the functional snRNA, RN7SK, further structured information can be provided for its biological properties, but not for the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 251 (RN7SKP251).